TCTR20190404002招募中2 期
The tuberculosis treatments by anti-tuberculosis dry powder prepared as nano-particulate system for inhaling into the respiratory system
Government Pharmaceutical Organization (GPO)0 个研究点目标入组 208 人开始时间: 2019年4月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 208
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •new case and retreatment pulmonary tuberculosis, sputum AFB positive, have clinical symptoms of TB (cough > 3 week, lose weight, night sweat, abnormal film CXR), comply to clinical trial, mono resistant pulmonary TB
排除标准
- •pregnancy and breast feeding, MDR TB, estimate peak expiratory flow rate > 60 L/min, ALT>125 U/L, HIV sero positive, allergy to research drugs, uncontrol asthma, copd, drug addict, use fluoroquinolone with in 30 days
研究者
相似试验
已完成
不适用
Mycobacteria infection in incomplete transverse myelitisIncomplete transverse myelitis (ITM)Nervous System DiseasesEncephalitis, myelitis and encephalomyelitisISRCTN57081310Sun Yat-sen University (China)67
进行中（未招募）
4 期
Anti-TB therapy following drug-induced liver injury (TB-DILI)Drug induced liver injury in patients receiving tuberculosis treatment.RespiratoryISRCTN92067975ottingham Clinical Trials Unit350
招募中
4 期
Implementing shorter treatment for latent tuberculosis in the Northern TerritoryLatent tuberculosis infectionInfection - Studies of infection and infectious agentsRespiratory - Other respiratory disorders / diseasesTuberculosisACTRN12619001704189TB Unit, Northern Territory Centre for Disease Control240
尚未招募
Unknown
To compare number of healthy household contacts aged between 6 to 18 years developing TB disease with tor without TB prophylactic therapy.CTRI/2023/04/052146Dr Poulomi Roy
已完成
不适用
Antibiotics for multidrug-resistant tuberculosis: network meta-analysis.MDR-TBJPRN-UMIN000039703Yokohama City University